Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors



Status:Archived
Conditions:Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:September 2008
End Date:January 2012

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Phase 1, Open Label, Sequential Cohort, Dose Escalation Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors


The study is being conducted to determine the maximum tolerated dose, overall safety and
tolerability profile, and pharmacokinetic profile of CP-751,871 and sunitinib when given in
combination with advanced solid tumors.



We found this trial at
3
sites
Fletcher Allen Health Care
111 Colchester Ave
Burlington, Vermont 05401
(802) 847-0000
Fletcher Allen Health Care As Vermont’s University Medical Center, we at Fletcher Allen are committed...
?
mi
from
Burlington, VT
Click here to add this to my saved trials
Pfizer Investigational Site
Houston, Texas 77030
?
mi
from
Houston, TX
Click here to add this to my saved trials
Pfizer Investigational Site
Los Angeles, California 90027
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials